Effect of type 2 diabetes on A disintegrin and metalloprotease 10.

Sum LamSammy Wing-Ming ShiuYing WongKathryn Choon Beng Tan

Published in: Journal of diabetes (2022)

Serum concentration of ADAM10 is increased in type 2 diabetes and is associated with glycemia and insulin therapy, which may potentially affect the specificity of systemic ADAM10 level as a biomarker.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
insulin resistance
stem cells
metabolic syndrome
weight loss
drug induced
replacement therapy